Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
170 Locke Drive, Marlborough, MA, 01752, US
Expands biomanufacturing services
By: Tim Wright
Boosts single-use biopharma manufacturing business
By: Gil Roth
Xcellerex, Inc. and Gallus BioPharmaceuticals, LLC have entered into a collaboration to provide Gallus with expanded cGMP biomanufacturing capacity using Xcellerex’s FlexFactory GMP manufacturing platform suite.
Xcellerex, Inc. has received the Invensys Operations Management OPEN award for “innovative use of Invensys products and solutions to generate considerable business results” in four Operational Excellence categories.
Xcellerex, Inc. began construction of a cGMP FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA, with completion scheduled for September 2010.
Guy Broadbent has been appointed president and chief executive officer of Xcellerex, Inc., as well as a member of the company’s board of directors.
Xcellerex, Inc. and Humacyte, Inc. have entered into a strategic collaboration under which Xcellerex will develop a manufacturing process enabling the production of Humacyte’s lead regenerative drug product using its XDR single-use bioreactor system
Xcellerex, Inc. has initiated a Phase I trial of XRX-001, a prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.
By: Eric Langer
Jonathan Lieber has been appointed chief financial officer, Xcellerex, Inc. Mr. Lieber joins the company from Altus Pharmaceuticals, where he was senior vice president, chief financial officer, and treasurer.
Crucell N.V. is acquiring Xcellerex, Inc.'s FlexFactory bioproduction line and multiple XDR single-use bioreactors as part of its effort to expand capacity and flexibility of its manufacturing capabilities.
Xcellerex, Inc., along with three collaborators, has been awarded an $11 million Phase II contract by the Defense Threat Reduction Agency (DTRA) - Joint Science and Technology Office, Transformational Medical Technologies Initiative (TMTI), to develop tec
The outlook is bright for CMOs
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
